Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DTDEC-01 by Dystrogen Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
DTDEC-01 is under clinical development by Dystrogen Therapeutics and currently in Phase I for Duchenne Muscular Dystrophy. According to GlobalData,...